Search research articles
Contact Us
Filters
Showing results (41-50 of 186) with videos related to
Page
of 19
Sort By:
Cancer
|
January 15, 1993
Mechanisms of drug resistance in ovarian cancer
S W Johnson, R F Ozols, T C Hamilton
Progress in Clinical and Biological Research
|
January 1, 1988
Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer
R F Ozols, T C Hamilton, R C Young
The Journal of Pharmacy and Pharmacology
|
November 1, 1980
Involvement of central alpha 2-adrenoceptors in the mediation of clonidine-induced hypotension in the cat
T C Hamilton, A A Hunt, R H Poyser
Cancer
|
October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovary
T C Hamilton, R F Ozols, D L Longo
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1999
Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?
T C Hamilton, J S Berek, S B Kaye
Oncology (Williston Park, N.Y.)
|
March 1, 1990
Multidrug resistance to alkylating agents and platinum compounds: state of our knowledge
T C Hamilton, R F Ozols, M B Dabrow
Molecular and Cellular Endocrinology
|
February 1, 1994
Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells
C H Chien, F F Wang, T C Hamilton
Seminars in Oncology
|
September 1, 1984
Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches
T C Hamilton, R C Young, R F Ozols
Pharmacology & Therapeutics
|
January 1, 1990
Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems
R P Perez, T C Hamilton, R F Ozols
Cancer Treatment and Research
|
June 10, 1998
Molecular biology of gynecologic malignancies
T C Hamilton, S W Johnson, A K Godwin
Page
of 19
Search research articles
Search
Showing results (41-50 of 186) with videos related to
Sort By:
Page
of 19
Cancer
|
January 15, 1993
Mechanisms of drug resistance in ovarian cancer
S W Johnson, R F Ozols, T C Hamilton
Progress in Clinical and Biological Research
|
January 1, 1988
Cellular glutathione levels and sensitivity to radiation and antineoplastic agents in human ovarian cancer
R F Ozols, T C Hamilton, R C Young
The Journal of Pharmacy and Pharmacology
|
November 1, 1980
Involvement of central alpha 2-adrenoceptors in the mediation of clonidine-induced hypotension in the cat
T C Hamilton, A A Hunt, R H Poyser
Cancer
|
October 15, 1987
Biologic therapy for the treatment of malignant common epithelial tumors of the ovary
T C Hamilton, R F Ozols, D L Longo
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 1999
Basic research: how much do we know, and what are we likely to learn about ovarian cancer in the near future?
T C Hamilton, J S Berek, S B Kaye
Oncology (Williston Park, N.Y.)
|
March 1, 1990
Multidrug resistance to alkylating agents and platinum compounds: state of our knowledge
T C Hamilton, R F Ozols, M B Dabrow
Molecular and Cellular Endocrinology
|
February 1, 1994
Transcriptional activation of c-myc proto-oncogene by estrogen in human ovarian cancer cells
C H Chien, F F Wang, T C Hamilton
Seminars in Oncology
|
September 1, 1984
Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches
T C Hamilton, R C Young, R F Ozols
Pharmacology & Therapeutics
|
January 1, 1990
Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems
R P Perez, T C Hamilton, R F Ozols
Cancer Treatment and Research
|
June 10, 1998
Molecular biology of gynecologic malignancies
T C Hamilton, S W Johnson, A K Godwin
Page
of 19